Inbox Robot: Acute Myeloid Leukemia News http://www.inboxrobot.com/news/acute-myeloid-leukemia Constantly updated news and information about a variety of topics. Zeroing in on PI3K Pathway http://www.inboxrobot.com/news.php?fid=201157206 1 Dec 2008 14:31 GMT ... Phase I study in hematologic cancer patients (chronic lymphocytic leukemia, B-cell non-Hodgkin lymphoma, and acute myeloid leukemia). The company has a second candidate moving into clinical development later this year indicated ... Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH http://www.inboxrobot.com/news.php?fid=201148739 1 Dec 2008 13:50 GMT Title: "A Phase 1 Trial of SNS-032, a Potent and Specific CDK 2, 7 and 9 Inhibitor, in Chronic Lymphocytic Leukemia and Multiple Myeloma" ... Astex Presents Updates on AT7519 and AT9283 at the American Society of Hematology (ASH) Conference http://www.inboxrobot.com/news.php?fid=201138178 1 Dec 2008 12:13 GMT ... A (Moscone Center) Abstract Number: 1104 Poster Board: I-209 iv) Poster Title: Inhibition of Acute Myeloid Leukemia by AT9283 Is Dependent upon the Presence or Absence of Mutations in Type 1 ... Three-Month, Updated FDA Decision Calendar http://www.inboxrobot.com/news.php?fid=201129157 1 Dec 2008 10:50 GMT ... a sNDA earlier this week to expand the use of Clolar for adults with acute myeloid leukemia (AML) and should hear back from the FDA by the end of January whether ... Sunesis to cut 60 jobs, refocus business http://www.inboxrobot.com/news.php?fid=201122250 1 Dec 2008 09:57 GMT ... as a single agent for the treatment of platinum-resistant ovarian cancer and previously untreated acute myeloid leukemia. ...